EP0674705A4 - Oligonucleotides antisens utilises pour inhiber l'expression de genes de collagene ayant subis une mutation et de type sauvage. - Google Patents

Oligonucleotides antisens utilises pour inhiber l'expression de genes de collagene ayant subis une mutation et de type sauvage.

Info

Publication number
EP0674705A4
EP0674705A4 EP94901327A EP94901327A EP0674705A4 EP 0674705 A4 EP0674705 A4 EP 0674705A4 EP 94901327 A EP94901327 A EP 94901327A EP 94901327 A EP94901327 A EP 94901327A EP 0674705 A4 EP0674705 A4 EP 0674705A4
Authority
EP
European Patent Office
Prior art keywords
mutated
collagen
wild type
antisense oligonucleotides
inhibit expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94901327A
Other languages
German (de)
English (en)
Other versions
EP0674705A1 (fr
Inventor
Darwin Prockop
Alain Colige
Renato Baserga
Paul Nugent
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thomas Jefferson University
Original Assignee
Thomas Jefferson University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas Jefferson University filed Critical Thomas Jefferson University
Publication of EP0674705A1 publication Critical patent/EP0674705A1/fr
Publication of EP0674705A4 publication Critical patent/EP0674705A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP94901327A 1992-11-09 1993-11-09 Oligonucleotides antisens utilises pour inhiber l'expression de genes de collagene ayant subis une mutation et de type sauvage. Withdrawn EP0674705A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97333292A 1992-11-09 1992-11-09
US973332 1992-11-09
PCT/US1993/010756 WO1994011494A1 (fr) 1992-11-09 1993-11-09 Oligonucleotides antisens utilises pour inhiber l'expression de genes de collagene ayant subis une mutation et de type sauvage

Publications (2)

Publication Number Publication Date
EP0674705A1 EP0674705A1 (fr) 1995-10-04
EP0674705A4 true EP0674705A4 (fr) 1997-11-26

Family

ID=25520770

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94901327A Withdrawn EP0674705A4 (fr) 1992-11-09 1993-11-09 Oligonucleotides antisens utilises pour inhiber l'expression de genes de collagene ayant subis une mutation et de type sauvage.

Country Status (4)

Country Link
EP (1) EP0674705A4 (fr)
JP (1) JPH08503366A (fr)
CA (1) CA2148687A1 (fr)
WO (1) WO1994011494A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156513A (en) * 1995-09-15 2000-12-05 Ramareddy V. Guntaka Oligmers which inhibit expression of collagen genes
US5780611A (en) * 1995-09-15 1998-07-14 Ramareddy Venkata Guntaka Oligomers which inhibit expression of collagen genes
US5808037A (en) * 1995-09-15 1998-09-15 Ramareddy Venkata Guntaka Oligomers which inhibit expression of collagen genes
GB9519299D0 (en) 1995-09-21 1995-11-22 Farrar Gwyneth J Genetic strategy
GB9604449D0 (en) * 1996-03-01 1996-05-01 Farrar Gwyneth J Genetic strategy ii
US8551970B2 (en) 1996-04-02 2013-10-08 Optigen Patents Limited Genetic suppression and replacement
GB9606961D0 (en) * 1996-04-02 1996-06-05 Farrar Gwyneth J Genetic strategy III
US5814500A (en) * 1996-10-31 1998-09-29 The Johns Hopkins University School Of Medicine Delivery construct for antisense nucleic acids and methods of use
AU6764398A (en) * 1997-03-20 1998-10-12 Variagenics, Inc. Target genes for allele-specific drugs
US6200754B1 (en) 1998-03-19 2001-03-13 Variagenics, Inc. Inhibitors of alternative alleles of genes encoding products that mediate cell response to environmental changes
US6939712B1 (en) * 1998-12-29 2005-09-06 Impedagen, Llc Muting gene activity using a transgenic nucleic acid
GB9929487D0 (en) * 1999-12-15 2000-02-09 Zeneca Ltd Antisense oligonucleotides

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006934A1 (fr) * 1988-12-20 1990-06-28 Baylor College Of Medicine Acide nucleique a triple brin et procedes d'utilisation
WO1993004701A1 (fr) * 1991-09-05 1993-03-18 University Of Connecticut Apport cible de polynucleotides ou d'oligonucleotides a des cellules

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006934A1 (fr) * 1988-12-20 1990-06-28 Baylor College Of Medicine Acide nucleique a triple brin et procedes d'utilisation
WO1993004701A1 (fr) * 1991-09-05 1993-03-18 University Of Connecticut Apport cible de polynucleotides ou d'oligonucleotides a des cellules

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
COLIGE, A. ET AL.: "Use of an antisense oligonucleotide to inhibit expression of a mutated human procollagen gene ( COL1A1 ) in transfected mouse 3T3 cells.", BIOCHEMISTRY, (1993 JAN 12) 32 (1) 7-11., XP002032408 *
COLIGE, A. ET AL.: "USE OF AN ANTISENSE OLIGONUCLEOTIDE TO INHIBIT EXPRESSION OF A MUTATED HUMAN PROCOLLAGEN GENE (COL1A1) IN TRANSFECTED MOUSE 3T3 CELLS.", MATRIX 13 (1). 1993. 30., XP002032407 *
FOURTH INTERNATIONAL CONFERENCE ON THE MOLECULAR BIOLOGY AND PATHOLOGY OF MATRIX, JUNE 10-13, 1992. *
See also references of WO9411494A1 *

Also Published As

Publication number Publication date
EP0674705A1 (fr) 1995-10-04
CA2148687A1 (fr) 1994-05-26
JPH08503366A (ja) 1996-04-16
WO1994011494A1 (fr) 1994-05-26

Similar Documents

Publication Publication Date Title
US5446137B1 (en) Oligonucleotides containing 4'-substituted nucleotides
GR3015085T3 (en) Anti-sense regulation of gene expression in plant cells.
GB2187462B (en) Root-nodule specific expression of genes in root-nodule tissue and plants comprising root-nodules using promoters from root-nodule specific genes.
IL104536A0 (en) Gene transfer in birds by introduction of dna into muscle in ovo
EP0666923A4 (fr) Apport cible de polynucleotides ou d'oligonucleotides a des cellules.
EP0674705A4 (fr) Oligonucleotides antisens utilises pour inhiber l'expression de genes de collagene ayant subis une mutation et de type sauvage.
AU4944396A (en) Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof
GB9524350D0 (en) Enhancer-increased gene expression in plants
IL108367A0 (en) Antisense polynzcleotide inhibition of human growth factor-sensitive cancer cells
AU7572096A (en) Chimeric oligomers having an rna-cleavage activity
GB9514437D0 (en) Inhibition of gene expression
GB9224640D0 (en) Stable oligonucleotides
IL104537A0 (en) Gene transfer in birds by introduction of dna into muscle in ovo
AU6601690A (en) Selective inhibition of gene expression by photoactivatable oligonucleotides
EP0353290A4 (en) Selective inhibition of gene expression by photoactivatable oligonucleotides
GB9225427D0 (en) Oligonucleotides with rna cleavage activity
EP0672153A4 (fr) Vecteur transportant et exprimant un gene etranger.
ZA896423B (en) Factor regulating gene expression
HU9500979D0 (en) Antisense oligonucleotide inhibition of the ras gene
GB8901674D0 (en) Regulation of plant gene expression
ZA958381B (en) Regulated genes by stimulation of chondrocytes with 1l-1beta
EP0489846A4 (en) Antisense oligonucleotides to c-abl proto-oncogene
AU6548396A (en) Methods for selectively killing or inhibiting the growth of cells expressing the waf1 gene
EP0975650A4 (fr) Oligomeres inhibant l'expression de genes de collagene
HU9202483D0 (en) Multigen having self-splitting activity for expression of rna

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950609

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19971009

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19991206

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000418

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1010394

Country of ref document: HK